Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 7:00 PM ET

Date/Time Source News Release
05/13/2025 07:01 AM EDT PR Newswire Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update
04/30/2025 07:30 AM EDT PR Newswire Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
04/28/2025 07:30 AM EDT PR Newswire Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
04/17/2025 07:30 AM EDT PR Newswire Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
03/18/2025 07:01 AM EDT PR Newswire Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
03/10/2025 04:30 PM EDT PR Newswire Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering
03/07/2025 08:00 AM EST PR Newswire Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
03/03/2025 08:00 AM EST Canada Newswire Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics
02/28/2025 08:00 AM EST PR Newswire Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update
02/24/2025 08:00 AM EST PR Newswire Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI
Page

Additional News

As of June 7, 2025 • 7:00 PM ET

Date/Time Source News Release
05/21/2025 04:37 PM EDT SeekingAlpha Acurx files to sell 10.9M shares of common stock for holders
05/13/2025 02:00 PM EDT SeekingAlpha Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
05/13/2025 01:59 PM EDT SeekingAlpha Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
05/13/2025 08:07 AM EDT SeekingAlpha Acurx Pharmaceuticals GAAP EPS of -$0.11
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Acurx Pharmaceuticals Inc.
05/07/2025 12:42 PM EDT Zacks Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
04/08/2025 09:55 AM EDT Zacks Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
03/21/2025 12:00 PM EDT Zacks Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
03/18/2025 09:44 AM EDT SeekingAlpha Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript
Page